Substrate specificity of the cypemycin decarboxylase CypD

Arnison, 2013, Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature, Nat Prod Rep, 30, 108, 10.1039/C2NP20085F Hetrick, 2017, Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era, Curr Opin Chem Biol, 38, 36, 10.1016/j.cbpa.2017.02.005 Bartholomae, 2017, Major gene-regulatory mechanisms operating in ribosomally synthesized and post-translationally modified peptide (RiPP) biosynthesis, Mol Microbiol, 106, 186, 10.1111/mmi.13764 Mahanta, 2017, Radical S-adenosylmethionine enzymes involved in RiPP biosynthesis, Biochemistry, 56, 5229, 10.1021/acs.biochem.7b00771 Benjdia, 2017, Radical SAM enzymes in the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs), Front Chem, 5, 87, 10.3389/fchem.2017.00087 Hudson, 2018, RiPP antibiotics: biosynthesis and engineering potential, Curr Opin Microbiol, 45, 61, 10.1016/j.mib.2018.02.010 Letzel, 2014, Genome mining for ribosomally synthesized and post-translationally modified peptides (RiPPs) in anaerobic bacteria, BMC Genom, 15, 983, 10.1186/1471-2164-15-983 Claesen, 2010, Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides, Proc Natl Acad Sci U S A, 107, 16297, 10.1073/pnas.1008608107 Claesen, 2011, Biosynthesis and regulation of grisemycin, a new member of the linaridin family of ribosomally synthesized peptides produced by Streptomyces griseus IFO 13350, J Bacteriol, 193, 2510, 10.1128/JB.00171-11 Rateb, 2015, Legonaridin, a new member of linaridin RiPP from a Ghanaian Streptomyces isolate, Org Biomol Chem, 13, 9585, 10.1039/C5OB01269D Mo, 2017, Biosynthetic insights into linaridin natural products from genome mining and precursor peptide mutagenesis, ACS Chem Biol, 12, 1484, 10.1021/acschembio.7b00262 Komiyama, 1993, A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristics, J Antibiot (Tokyo), 46, 1666, 10.7164/antibiotics.46.1666 Minami, 1994, Structure of cypemycin, a new peptide antibiotic, Tetrahedron Lett, 35, 8001, 10.1016/0040-4039(94)80033-2 Zhang, 2012, Catalytic promiscuity of a bacterial alpha-N-methyltransferase, FEBS Lett, 586, 3391, 10.1016/j.febslet.2012.07.050 Zhang, 2012, Evolution of lanthipeptide synthetases, Proc Natl Acad Sci U S A, 109, 18361, 10.1073/pnas.1210393109 van der Donk, 2014, Structure and mechanism of lanthipeptide biosynthetic enzymes, Curr Opin Struct Biol, 29, 58, 10.1016/j.sbi.2014.09.006 Repka, 2017, Mechanistic understanding of lanthipeptide biosynthetic enzymes, Chem Rev, 117, 5457, 10.1021/acs.chemrev.6b00591 Sit, 2011, Biosynthesis of aminovinyl-cysteine-containing peptides and its application in the production of potential drug candidates, Acc Chem Res, 44, 261, 10.1021/ar1001395 Ortega, 2017, Two flavoenzymes catalyze the post-translational generation of 5-chlorotryptophan and 2-aminovinyl-cysteine during NAI-107 biosynthesis, ACS Chem Biol, 12, 548, 10.1021/acschembio.6b01031 Wiebach, 2018, The anti-staphylococcal lipolanthines are ribosomally synthesized lipopeptides, Nat Chem Biol, 14, 652, 10.1038/s41589-018-0068-6 Kupke, 1995, Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry, J Biol Chem, 270, 11282, 10.1074/jbc.270.19.11282 Majer, 2002, The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin, J Bacteriol, 184, 1234, 10.1128/JB.184.5.1234-1243.2002